search-icon
close icon

FDA Withdraws Two Temporary COVID FSMA Guidances

The U.S. Food and Drug Administration is withdrawing the following two temporary guidances, originally published during the COVID-19 public health emergency, regarding human and animal foods that involve onsite visits under the FDA Food Safety Modernization Act:

In these two documents, the agency issued guidance on onsite auditing and observations requirements, to assist firms responding to the COVID-19 pandemic and help ensure continued food safety and availability during the pandemic.

As COVID no longer causes travel to be impracticable to any significant extent, these temporary guidances are no longer relevant or needed and are being withdrawn. To ensure that industry is not surprised by the change in policy, the withdrawals will be effective in 90 days, or on 16 June, 2026.

Background

When the U.S. COVID-19 public health emergency declaration officially ended in May 2023, the FDA recognized certain firms might still be impacted by COVID-19 travel restrictions and advisories. Accordingly, in July 2023 the FDA reissued two temporary COVID-era FSMA guidances for certain regulatory requirements involving onsite activities.

When certain circumstances were present, including but not limited to, when COVID-19 travel restrictions prevented onsite visits, the temporary guidances addressed supplier onsite activities for the FSMA Preventive Controls for Human and Animal Food rules and the Foreign Supplier Verification Programs rule, and onsite monitoring activities and duration of already-issued certifications for the Accredited Third-Party Certification Program.

Additional Information:

Source: US Food and Drug Administration

Social Image
Social Image
Social Image
Social Image
Social Image
Social Image
Social Image
Social Image
Social Image